EU leaders raise doubts over U.S. plan to waive Covid vaccine patents

EU leaders have doubts that waiving intellectual property rights for Covid-19 vaccines is the way to go.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.